Ibrahim Gunay, MD | Psychiatrist.com

Original Research

Long-Term Safety and Tolerability of Rivastigmine in Patients With Alzheimer's Disease Switched From Donepezil: An Open-Label Extension Study

October 15, 2008

Gary S. Figiel, Barbara Koumaras, Xiangyi Meng, et al

Original Research

Safety and Efficacy of Rivastigmine in Patients With Alzheimer's Disease Not Responding Adequately to Donepezil: An Open-Label Study

August 15, 2008

Gary S. Figiel, Carl H. Sadowsky, John Strigas, et al

Original Research

Adding Memantine to Rivastigmine Therapy in Patients With Mild-to-Moderate Alzheimer's Disease: Results of a 12-Week, Open-Label Pilot Study

October 16, 2006

Matthias W. Riepe, Georg Adler, Bernd Ibach, et al

Original Research

Patterns of Concomitant Psychotropic Medication Use During a 2-Year Study Comparing Clozapine and Olanzapine for the Prevention of Suicidal Behavior

May 1, 2004

Ira D. Glick, Rocco Zaninelli, Chuanchieh Hsu, et al